Clinical trial

Cohort Study on Plant-based Diets (COPLANT Study)

Recruiting now · Not applicable · 2 countries · Registry ID NCT06323538

Recruiting nowNot applicableObservational

What this study is about

The Cohort on Plant-based Diets (COPLANT) study is a multi-centre cohort study that starts baseline recruitment from 2024 to 2027 with approximately 6,000 participants in Germany and Austria. The COPLANT study focuses on vegan (no animal products), vegetarian (no meat and fish, but dairy products and eggs), pescetarian (no meat, but fish) and omnivorous (mixed diet including all possible animal products) diets. The aim of the COPLANT study is to gain new insights on health benefits and risks as well as social, ecological and economic effects of different plant-based diets in comparison to a mixed diet. In addition to a detailed dietary survey using an app adapted to the needs of this study, the baseline examination includes measurements of body composition, bone health, cardiovascular risk factors, diabetes risk, contaminants and lifestyle. For the basic laboratory program, fasting blood, 24-hour urine collection and a stool sample are taken from all study participants. Furthermore, specific aspects of dietary behavior, physical activity and other lifestyle factors are collected via questionnaires. Follow-up studies are planned at intervals of 5, 10 and 20 years after the baseline visit.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to 69 Years
SexAll
Healthy volunteersNot listed
ConditionDietary Exposure, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Bone Loss, Sustainability, Exposure, Obesity, Vitamin Deficiency, Mineral Deficiency

Full registry criteria

Inclusion Criteria: * age between 18 and 69 years at recruitment (age-stratified recruitment in four age groups (18 to 29, 30 to 39, 40 to 49 and 50 to 69 years) which should be equally distributed across the four diets) * following their current diet for at least one year * health insured * are willing to have blood taken (adults) * are willing and able to complete questionnaires * only at Berlin, Jena, Giessen and Karlsruhe sites: pregnant and breastfeeding women were recruited (shortened examination programm) * only at the Regensburg, Heidelberg, Bonn and Vienna sites: are neither pregnant nor breastfeeding at the time of recruitment * only at Berlin and Karlsruhe sites: children of adult participants (shortened examination programm without collection of blood, urine, and stool) * are able to give informed consent to participate in the study * have given their consent to participate in the COPLANT study Exclusion Criteria: * who can no longer be contacted * who withdraw their consent to participate in the study

Treatments and study arms

The registry does not list a named intervention.

Primary outcomes

Incidence of diabetes type 25, 10, 20 years

Incidence of diabetes type 2

Study locations

8 locations were listed when this page was built. The first 40 are shown.

University Vienna🇦🇹 Vienna, Austria
Maria Wakolbinger, ProfContact
Tilman Kühn, ProfContact
The German Federal Institut for Risk Assessment🇩🇪 Berlin, Germany
Cornelia Weikert, ProfContact
University Bonn🇩🇪 Bonn, Germany
Ute Nöthlings, ProfContact
Research Institute for Plant-Based Nutrition, Gießen🇩🇪 Giessen, Germany
Markus Keller, PhDContact
University Heidelberg🇩🇪 Heidelberg, Germany
Ina DanquahContact
Friedrich-Schiller University🇩🇪 Jena, Thuringia, Germany
Christine Dawczynski, PhDContact
Max Rubner-Institut🇩🇪 Karlsruhe, Baden-Wurttemberg, Germany
Benedikt Merz, PhDContact
University Regensburg🇩🇪 Regensburg, Germany
Michael Leitzmann, ProfContact
Beate FischerContact